Kit Beyer

Dr. Kit Beyer

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
AVAdam Vert
Adam Vert
KWKyle S. Weber
Kyle S. Weber
VTVanessa Thai
Vanessa Thai
ETErin Turner
Erin Turner
KBKit Beyer
Kit Beyer
KOKaren Van Ooteghem
Karen Van Ooteghem
Background: Accelerometery is commonly used to estimate physical activity, sleep, and sedentary behavior. In free-living conditions, periods of device removal (non-wear) can lead to misclassification of behavior with consequences for research outcomes and clinical decision making. Common methods for non-wear detection are limited by data transformations (e.g., activity counts) or algorithm parameters such as minimum durations or absolute temperature thresholds that risk over- or under-estimating non-wear time. This study aimed to advance non-wear detection methods by integrating a ‘rate-of-change’ criterion for temperature into a combined temperature-acceleration algorithm. Methods: Data were from 39 participants with neurodegenerative disease (36% female; age: 45–83 years) who wore a tri-axial accelerometer (GENEActiv) on their wrist 24-h per day for 7-days as part of a multi-sensor protocol. The reference dataset was derived from visual inspection conducted by two expert analysts. Linear regression was used to establish temperature rate-of-change as a criterion for non-wear detection. A classification and regression tree (CART) decision tree classifier determined optimal parameters separately for non-wear start and end detection. Classifiers were trained using data from 15 participants (38.5%). Outputs from the CART analysis were supplemented based on edge cases and published parameters. Results: The dataset included 186 non-wear periods (85.5% < 60 min). Temperature rate-of-change over the first five minutes of non-wear was − 0.40 ± 0.17 °C/minute and 0.36 ± 0.21 °C/minute for the first five minutes following device donning. Performance of the DETACH (DEvice Temperature and Accelerometer CHange) algorithm was improved compared to existing algorithms with recall of 0.942 (95% CI 0.883 to 1.0), precision of 0.942 (95% CI 0.844 to 1.0), F1-Score of 0.942 (95% CI 0.880 to 1.0) and accuracy of 0.996 (0.994–1.000). Conclusion: The DETACH algorithm accurately detected non-wear intervals as short as five minutes; improving non-wear classification relative to current interval-based methods. Using temperature rate-of-change combined with acceleration results in a robust algorithm appropriate for use across different temperature ranges and settings. The ability to detect short non-wear periods is particularly relevant to free-living scenarios where brief but frequent removals occur, and for clinical application where misclassification of behavior may have important implications for healthcare decision-making.

1 March 2017 in Neuroscience
Verified
Journal Article
Closed access
KBKit Beyer
Kit Beyer
MSMichael D. Sage
Michael D. Sage
WSWilliam Richard Staines
William Richard Staines
LMLaura E. Middleton
Laura E. Middleton
WMWilliam McIlroy
William McIlroy

27 October 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMarla Beauchamp
Marla Beauchamp
RKRenata N Kirkwood
Renata N Kirkwood
CCCody Cooper
Cody Cooper
WMWilliam E McIlroy
William E McIlroy
KOKaren Van Ooteghem
Karen Van Ooteghem
MIMacM3 Investigators
MacM3 Investigators
Purpose The McMaster Monitoring My Mobility (MacM3) study aims to understand trajectories of mobility decline in later life using multisensor wearable technology. To our knowledge, MacM3 is the first major cohort to combine accelerometry and a Global Positioning System (GPS) to track real-world mobility in community-dwelling older adults. Participants Between May 2022 and May 2024, MacM3 recruited 1555 community-dwelling older adults (mean age 73.9 years, SD=5.5) from Hamilton and Toronto, Ontario. Of the cohort, 68.4% were female, 62.4% married/partnered, 75.3% had post-secondary education and 62.9% had≥3 comorbidities. Most were Canadian born (69.4%) and white/Caucasian (88.0%), with greater ethnocultural diversity observed at the Toronto site. Findings to date At baseline, 56.7% of participants reported no mobility limitations, 15.9% had preclinical limitations and 27.4% had minor mobility limitations. Mean gait speed for the total sample was 1.23 m/s, with a mean Timed Up and Go time of 9.4 s and a 5× sit-to-stand time of 13.0 s. A total of 1301 participants had valid wrist-worn device data, and 1008 participants who agreed to wear the thigh-worn device had valid data (≥7 days with ≥10 hours of wear per day). Step count data (n=1008) revealed a mean of 8437 steps per day (SD=2943), with 5073 steps in the lowest quartile and 12 303 steps in the highest. Future plans Ongoing work aims to develop predictive models of mobility decline by integrating wearable, clinical and environmental data. Pipeline enhancements will enable GPS/inertial measurement unit fusion to explore mobility-environment interactions and support ageing-in-place tools.

12 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
ASAishwarya Shenoy
Aishwarya Shenoy
MSManvir Singh Samra
Manvir Singh Samra
KOKaren Van Ooteghem
Karen Van Ooteghem
KBKit Beyer
Kit Beyer
STSherri Thomson
Sherri Thomson
CPCourtney L. Pollock
Courtney L. Pollock
Stroke is the most common cause of disability in adults, resulting in declines in overall activity. Inertial measurement units (IMUs) allow for the monitoring of activity patterns in various settings, informing clinical interventions and patient self-management. This review aimed to synthesize existing research evaluating the usability of IMUs for monitoring activity in people with stroke. This scoping review was conducted according to PRISMA guidelines. The MEDLINE, Embase, and CINAHL databases were searched for publications evaluating the usability of IMUs for monitoring activity post-stroke. Fourteen publications met the inclusion criteria. Most studies were conducted in chronic stroke with data collected in real-world conditions. Usability findings indicated that most stroke participants and clinicians reported a positive user experience; however many reported difficulties with devices due to stroke-related impairments. Importantly, the interpretation of this finding was impacted by poorly reported impairments of stroke participants. Only a few studies evaluated end-user experiences (people with stroke and clinicians) in interpreting and engaging with feedback based on data from IMUs. Future usability studies in stroke populations should aim to understand participant characteristics that influence device engagement, with a focus on user experience in interpreting device-generated metrics.

1 May 2025 in Digital Health
Verified
Journal Article
Open access
FGF Elizabeth Godkin
F Elizabeth Godkin
KOKaren Van Ooteghem
Karen Van Ooteghem
KBKit Beyer
Kit Beyer
KWKyle S. Weber
Kyle S. Weber
BCBenjamin F Cornish
Benjamin F Cornish
WMWilliam E McIlroy
William E McIlroy
Objective: Advances in the collection of high-quality, continuous electrocardiography (ECG) data via wearable technology have the potential to transform heart rate (HR) measurement in daily life. This study aimed to characterize the impact of methodological criteria and behavioral context on estimates of resting heart rate (RHR) to guide recommendations for a standardized approach to measure daily life RHR. Methods: Ten adults (9 female, 61 ± 12 years) wore a chest-mounted ECG device and wrist and ankle movement sensors continuously for 7–10 days. Following signal quality screening and beat-to-beat calculations, HR was analyzed using rolling averages of 15-, 30-, and 60-s windows within periods of device-detected sedentary behavior and sleep. ECG data during sedentary and sleep were compared for differences in: (1) RHR, (2) between-day consistency of daily RHR, and (3) HR median and range. Results: During sedentary and sleep, respectively, there was no difference in RHR (56 ± 7 vs. 54 ± 7 bpm, p = 0.055) or in between-day consistency of RHR (coefficient of variation: 6 ± 3% vs. 5 ± 3%, p = 0.12; maximum between-day range of RHR=14 bpm). However, the median HR (71 ± 6 vs. 62 ± 7 bpm, p = 0.001) and HR range (35 ± 6 vs. 23 ± 7 bpm, p < 0.01) were significantly greater during sedentary versus sleep. Conclusions: Behavioral context and method of analysis impact ECG-based HR measures at rest. This study recommends a novel wearable-based method for measuring daily life RHR that maximizes use of available data and confronts variability that exists with extended monitoring. Use of a standard method for measuring daily life RHR may advance the use of HR to inform clinical and/or personal health decisions.

25 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAishwarya Shenoy
Aishwarya Shenoy
KBKit Beyer
Kit Beyer
WMWilliam McIlroy
William McIlroy
KOKaren Van Ooteghem
Karen Van Ooteghem
KWKyle S. Weber
Kyle S. Weber
CPCourtney L. Pollock
Courtney L. Pollock
In accelerometer-based measurement, inclusion of upper extremity (UE) activity during walking can overestimate real-world functional UE use in people post-stroke. This study introduces a comprehensive, accelerometer-based approach to examine real-world UE use, including contribution of UE activity during walking, and compares UE use during walking versus ADL-based activities. People with subacute stroke wore bilateral wrist and ankle inertial measurement units (IMU) for one week (24 hrs/day). Agreement between UE-Total, UE-Continuous Walking, and UE-ADL measures were assessed using Bland–Altman analyses. Variables were modeled using linear regression to explore step count, mobility aid use and UE motor impairment as predictors of IMU measures of real-world UE use. Agreement between UE-Total and UE-ADL measures showed minimal bias. Differences between UE-Continuous Walking and UE-ADL varied by mobility aid. UE-Continuous Walking was associated with increased UE activity and relatively greater paretic arm use compared with UE-ADL. Across UE-Continuous Walking and UE-ADL, step count was the strongest predictor of real-world UE use. UE activity during continuous walking exhibits different use patterns as compared to ADL-based activity. Accordingly, separating continuous walking-related UE activity from ADL-based UE use may improve clinical interpretation of IMU measures of real-world UE use in individuals with subacute stroke.